Abstract
The study has three aims; firstly to establish if, having been informed of their risk status and that gene testing is inappropriate for them, low and moderate risk patients have misunderstood or failed to grasp this and want a test that is inappropriate for them. Secondly, to elicit patients’ willingness to pay for cancer genetic services. Thirdly, to ascertain the aspects of cancer genetics services that are important to high risk patients and present service configurations prioritised in terms of preferences accompanied by their costs (cost-consequences analysis). Patient preferences were gathered from 120 patients returning a self-administered discrete choice questionnaire issued post genetic risk assessment. Patients at low and moderate risk of developing breast cancer desired inappropriate testing. Patients at high, moderate and low risk of developing genetic cancer were willing to pay up to £3,000 for genetic serviced, which exceeds the current estimated cost of providing testing and counselling. Counselling by a genetics associate accompanied by favourable levels of other attributes provided high utility and substantial cost savings.
Similar content being viewed by others
Abbreviations
- CGSW:
-
Cancer Genetics Service in Wales
- DCM:
-
Discrete choice modelling
- FAP or FAPC:
-
Familial adenomatous polyposis coli
- GP:
-
General practitioner
- HNPCC:
-
Hereditary nonpolyposis colorectal cancer
- NHS:
-
National Health Service
References
Lynch HT, Albano WA, Danes BS et al (1984) Genetic predisposition to breast cancer. Cancer 3:612–622. doi :10.1002/1097-0142(19840201)53:3+<M;612::AID-CNCR2820531306>3.0.CO;2-5
Landis SH, Murray T, Bolden S et al (1999) Cancer statistics. CA Cancer J Clin 49:8–31. doi:10.3322/canjclin.49.1.8
Malanders S, Ridderheim M, Masback A et al (2004) One in 10 ovarian cancer patients carry germline BRCA1 or BRCA2 mutations. Results of a prospective study in Southern Sweden. Eur J Cancer 40(3):422–428. doi:10.1016/j.ejca.2003.09.016
Risch HA, McLaughlin JR, Cole DEC et al (2001) Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in population series of 649 women with ovarian cancer. Am J Hum Genet 68:700–711. doi:10.1086/318787
Miki Y, Swensen J, Shattuck-Eidens D et al (1994) A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266:66–71. doi:10.1126/science.7545954
Wooster R, Bignell G, Lancaster J et al (1995) Identification of the breast cancer susceptibility gene BRCA2. Nature 378:789–792. doi:10.1038/378789a0
Aaltonen LA, Salovaara R, Kristo P et al (1989) Incidence of hereditary nonpolyposis cancer and the feasibility of molecular screening for the disease. N Engl J Med 338(21):1481–1487. doi:10.1056/NEJM199805213382101
Soravia C, Bapat B, Cohen Z (1997) Familial adenomatous polyposis (FAP) and hereditary nonpolyposis colorectal cancer (HNPCC): a review of clinical, genetic and therapeutic aspects. Schweiz Med Wochenschr 127:682–690
Griffith GL, Edwards RT, Gray J (2004) Cancer genetics services: a review of the economic evidence and issues. Br J Cancer 90(9):1697–1703
National Institute for Health Clinical Excellence (2006) The Nice guideline (41). Familial breast cancer: the classification and care of women at risk of familial breast cancer in primary, secondary and tertiary care. National Institute for Health and Clinical Excellence, London
Torrance N, Mollison J, Wordsworth S et al (2006) Genetic nurse counsellors can be an acceptable and cost-effective alternative to clinical geneticists for breast cancer risk genetic counselling. Evidence from two parallel randomised controlled equivalence trials. Br J Cancer 95(4):435–444. doi:10.1038/sj.bjc.6603248
Wilson B, Ryan M, Haites N (1999) Assessing user preferences for, and costs of, genetic counselling for familial cancer risk in Scotland: a cost-utility analysis using conjoint analysis. Chief Scientist Office, Edinburgh
Ryan M, McIntosh E, Shackley P (1998) Using conjoint analysis to elicit the views of health service users: an application to the patient health card. Health Expect 1:117–129. doi:10.1046/j.1369-6513.1998.00024.x
Ryan M (1996) Using consumer preferences in health care decision making. The application of conjoint analysis. Office of Health Economics, London
Wonderling D, Hopwood P, Cull A et al (2001) A descriptive study of UK cancer genetic services: an emerging clinical response to the new genetics. Br J Cancer 85(2):166–170. doi:10.1054/bjoc.2001.1893
Brain K, Gray J, Norman P et al (2000) Why do women attend familial breast cancer clinics? J Med Genet 37:1–5. doi:10.1136/jmg.37.3.197
Turner J, France BW, Wilcinson C et al (2002) All Wales cancer genetics service: final report November 2002. Department of General practice, University of Wales College of Medicine, Wrexham
Farrar S, Ryan M, Ross D et al (1997) Prioritisation of clinical service developments in a teaching hospital: an application of conjoint analysis. University of Aberdeen, Aberdeen
Parker BR, Srinivasan V (1976) A consumer preference approach to the planning of rural primary health care facilities. Oper Res 24(5):991–1025
Louviere JJ, Hensher DA, Swait JD (2000) Stated choice methods: analysis and application. Cambridge University Press, Cambridge
Bradley M (1991) Users manual for the speed version 2.1 stated preference experiment editor and designer. Hague Consulting Group, The Hague
Greene WH (1998) Limdep version 7.0. Econometric software, Inc., New York
Viney R, Lancsar E, Louviere J (2002) Discrete choice experiments to measure consumer preference for health and health care. Expert Rev Pharmacoeconomics Outcomes Res 2(4):319–326. doi:10.1586/14737167.2.4.319
Bech M, Gyrd-Hansen D (2005) Effects coding in discrete choice experiments. Health Econ 14(S1):S41–S57. doi:10.1002/hec.984
Griffith GL, Edwards RT, Gray J et al (2005) A micro costing of NHS cancer genetic services. Br J Cancer 92(1):60–71. doi:10.1038/sj.bjc.6602270
Office for National Statistics (2003) Census 2001. Office for National Statistics. http://www.statistics.gov.uk/census2002/profiles/printv/w-A.asp
Rose D, O’Reilly K (1998) The ESRC review of government social classifications. Office for National Statistics & Economic and Social Research Council, London & Swindon
San Miguel F, Ryan M, Amaya-Amaya M (2005) Irrational stated preferences: a quantitative and qualitative investigation. Health Econ 14:307–322. doi:10.1002/hec.912
Verhoef CG, Maas A, Stalpers LJA et al (1991) The feasibility of additive conjoint measurement in measuring utilities in breast cancer patients. Health Policy 17:39–50. doi:10.1016/0168-8510(91)90116-F
Hanson K, McPake B, Nakamba P et al (2005) Preference for hospital quality in Zambia: results from a discrete choice experiment. Health Econ 14:687–701. doi:10.1002/hec.959
McIntosh E, Ryan M (2002) Using discrete choice experiments to derive welfare estimates for the provision of elective surgery: implications of discontinuous preferences. J Econ Psychol 23:367–382. doi:10.1016/S0167-4870(02)00081-8
Ratcliffe J, Buxton M (1999) Patient preferences regarding the process and outcomes of life-saving technology. Int J Technol Assess Health Care 15(2):340–351
Hall J, Kenny P, King M et al (2002) Using stated preference discrete choice modelling to evaluate the introduction of varicella vaccination. Health Econ 11:457–465. doi:10.1002/hec.694
Lancsar E, Savage E (2004) Deriving welfare measures from discrete choice experiments: a response to Ryan and Santos Silva. Health Econ 13:919–924. doi:10.1002/hec.885
Bryan S, Buxton M, Sheldon R et al (1998) Magnetic resonance imaging for the investigation of knee injuries: a discrete choice conjoint analysis exercise. Health Econ 7:595–603. doi :10.1002/(SICI)1099-1050(1998110)7:7<595::AID-HEC381>3.0.CO;2-E
Bryan S, Dolan P (2004) Discrete choice experiments in health economics. Eur J Health Econ 5:199–202. doi:10.1007/s10198-004-0241-6
Scott A (2001) Eliciting GPs’ preferences for pecuniary and non-pecuniary job characteristics. J Health Econ 20:329–347. doi:10.1016/S0167-6296(00)00083-7
Steel M, Smyth E, Vasen H et al (1999) Ethical, social and economic issues in familial breast cancer: a compilation of views from the E.C. Biomed II demonstration project. Dis Markers 15(1–3):125–131
Harper PS, Clarke AJ (1997) Genetics and society in clinical practice. Bios Scientific publishers, Oxford
Advisory Committee on Genetics Testing (1998) Genetic testing for late onset disorders (Harper report). Health Department of the United Kingdom, London
Genetics Research Advisory Group (1995) A second report to the NHS Central Research and Development Committee on the new genetics. Department of Health, HMSO, London
Royal College of Physicians (1991) Clinical genetic services in 1990 and beyond. Royal College of Physicians, London
Griffith GL (2008) Patient preferences in the delivery of cancer genetic services. Bangor University, Bangor
Monroe KB (1971) Psychophysics of price: a reappraisal. J Mark Res 8:248–251. doi:10.2307/3149772
Dawes R, Corrigan B (1974) Linear models in decision making. Psychol Bull 81:95–106. doi:10.1037/h0037613
Clarke A, Parsons E, Williams A (1996) Outcome and process in genetic counselling. Clin Genet 50:462–469
Hundley V, Ryan M (2004) Are women’s expectations and preferences for intrapartum care affected by the model of care on offer? BJOG 111:550–560. doi:10.1111/j.1471-0528.2004.00152.x
Acknowledgements
We are grateful to all the patients and staff of the Cancer Genetics Service in Wales that participated in this research. We also wish to thank the anonymous reviewers for their valuable comments.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Griffith, G.L., Edwards, R.T., Williams, J.M.G. et al. Patient preferences and National Health Service costs: a cost-consequences analysis of cancer genetic services. Familial Cancer 8, 265–275 (2009). https://doi.org/10.1007/s10689-008-9217-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10689-008-9217-5